Levocar ® Tablet: Each tablet contains Levocarnitine USP 330 mg.
Levocar ® Solution: Each 5 ml solution contains Levocarnitine USP 500 mg.
Levocarnitine is a naturally occurring substance required in mammalian energy
metabolism. It has been shown to facilitate long-chain fatty acid entry into cellular
mitochondria, thereby delivering substrate for oxidation and subsequent energy
production in the form of Adenosine Tri phosphate or ATP. Fatty acids are utilized as an
energy substrate in all tissues except the brain. In skeletal and cardiac muscle, fatty acids
are the main substrate for energy production.
Indication and Use
The supplemental Levocarnitine use is widely established in the management of cardiac
ischemia and peripheral arterial disease. It is generally indicated for cardio protection. It
lowers triglyceride levels and increases levels of HDL-cholesterol. It is used with benefits
in those with primary and secondary carnitine deficiency syndromes. There is also
evidence of its use in liver, kidney and immune disorders or in diabetes and Alzheimer’s
disease. There is little evidence that supplemental Levocarnitine boosts energy, increases
athletic performance or inhibits obesity
Supplemental Levocarnitine is generally well tolerated. However, few side effects
including transient nausea and vomiting, abdominal cramps, and diarrhea may occur.